Rosetta Genomics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 86

Employees

  • Latest Deal Type
  • Liquidation

Rosetta Genomics General Information

Description

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Diagnostic Equipment
Corporate Office
  • 10 Plaut Street, Science Park
  • POB 4059
  • Rehovot 76706
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosetta Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Liquidation 31-May-2018 00000 Completed Bankruptcy: Liquidation
12. Buyout/LBO (Add-on) 30-May-2018 000 000 Cancelled Profitable
11. PIPE 01-Dec-2016 000 00000 Completed Profitable
10. PIPE 14-Oct-2015 000 000.00 Completed Generating Revenue
9. 2PO 03-Aug-2012 000.00 000.00 000.00 Completed Generating Revenue
8. PIPE 29-Feb-2012 00.000 000.00 Completed Generating Revenue
7. PIPE 27-Oct-2011 0000 000.00 Completed Generating Revenue
6. PIPE 07-Mar-2011 00.000 000.00 Completed Generating Revenue
5. PIPE 16-Apr-2009 $8M $45.5M Completed Generating Revenue
4. IPO 27-Feb-2007 $26.2M $37.5M 000.00 Completed Startup
To view Rosetta Genomics’s complete valuation and funding history, request access »

Rosetta Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and de
Pharmaceuticals
Rehovot, Israel
86 As of 2016
00000
000000000000 00000

000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000000000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

000000

lore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
0.000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rosetta Genomics Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Veracyte Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
Foundation Medicine Formerly VC-backed Cambridge, MA 0000 00000 00000000000
Guardant Health Formerly VC-backed Palo Alto, CA 0000 00000 00000000 00000
Hain Lifescience Corporate Backed or Acquired Nehren, Germany 00 000000&0
Abbott Corporation North Chicago, IL 000000 000.00 000000000 00 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Rosetta Genomics Patents

Rosetta Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180043036-A1 Lipid assemblies and uses thereof and some ph and electrostatic modulating lipids to be used in said assemblies Active 04-Feb-2015 00000000000 0
CA-2945531-A1 Mirna expression signature in the classification of thyroid tumors Active 13-May-2014 0000000000
CA-2945531-C Mirna expression signature in the classification of thyroid tumors Inactive 13-May-2014 0000000000
US-20170356055-A1 Mirna expression signature in the classification of thyroid tumors Inactive 13-May-2014 0000000000
US-20190300963-A1 Mirna expression signature in the classification of thyroid tumors Inactive 13-May-2014 C12Q1/6886
To view Rosetta Genomics’s complete patent history, request access »

Rosetta Genomics Executive Team (18)

Name Title Board Seat Contact Info
Ron Kalfus Chief Financial Officer
Sigal Russo-Gueta Controller
Eti Meiri Ph.D Vice President
Kenneth Berlin JD Chief Executive Officer & President
You’re viewing 4 of 18 executive team members. Get the full list »

Rosetta Genomics Board Members (9)

Name Representing Role Since
Brian Markison Self Chairman & Board Member 000 0000
David Sidransky MD Self Board Member 000 0000
Gerald Dogon Rosetta Genomics Board Member 000 0000
Joshua Rosensweig JD Self Board Member 000 0000
Roy Davis Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Rosetta Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rosetta Genomics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CynoGen 13-Apr-2015 0000000000 00.00 Laboratory Services (Healthcare) 0000000 0
Parkway Clinical Laboratories 24-Jul-2008 Merger/Acquisition 00.00 Laboratory Services (Healthcare)
To view Rosetta Genomics’s complete acquisitions history, request access »

Rosetta Genomics Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
CynoGen 13-Apr-2015 000000000000000000 00.00 Completed
  • 0000000 00000000
Parkway Clinical Laboratories 24-Jul-2008 Merger/Acquisition 00.00 Completed
To view Rosetta Genomics’s complete exits history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »